Fan Wang

Biography

1984-1988 B.S, Jilin University   1988-1991 M.S, Jilin University 1994-1997 Ph.D, China Institute of Atomic Energy 1998-2000 Postdoctoral Fellow, Oak Ridge National Laboratory; Washington University School of Medicine 1991-2008 Assistant Professor, Associate Professor, and Professor, China Institute of Atomic Energy 2001-present Professor, Peking University Health Science Center 2013-present Professor and Principal Investigator (Guest), Institute of Biophysics, Chinese Academy of Sciences Professional Activities   Vice-chairman, Chinese Society for Molecular Imaging  Editorial Board, Bioconjugate Chemistry, Nuclear Science and Techniques  Associate Editor, Biophysics Reports  Awards and Honors  2011, National Outstanding Youth, NSFC  2008, Berson-Yalow Award, Society of Nuclear Medicine, USA  1984-1988 B.S, Jilin University   1988-1991 M.S, Jilin University 1994-1997 Ph.D, China Institute of Atomic Energy 1998-2000 Postdoctoral Fellow, Oak Ridge National Laboratory; Washington University School of Medicine 1991-2008 Assistant Professor, Associate Professor, and Professor, China Institute of Atomic Energy 2001-present Professor, Peking University Health Science Center 2013-present Professor and Principal Investigator (Guest), Institute of Biophysics, Chinese Academy of Sciences Professional Activities   Vice-chairman, Chinese Society for Molecular Imaging  Editorial Board, Bioconjugate Chemistry, Nuclear Science and Techniques  Associate Editor, Biophysics Reports  Awards and Honors  2011, National Outstanding Youth, NSFC  2008, Berson-Yalow Award, Society of Nuclear Medicine, USA 

Research Interest

Molecular imaging, a rapid growing research field in the last decade, provides a powerful tool for the noninvasive characterization and quantification of biological processes in living subjects at the cellular and molecular levels. Central to molecular imaging is the development of imaging probes. Our research interests focus on the design and development of a series of novel molecular probes targeted to the key biomarkers during disease progress. By optimizing in preclinical animal models and clinical trials, these novel probes are expected to play pivotal roles in early disease detection and staging, as well as real-time response monitoring towards personalized therapy.